FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048009634> ?p ?o ?g. }

• W3048009634 endingPage "1129" @default.
• W3048009634 startingPage "1121" @default.
• W3048009634 abstract "BackgroundBotulinum neurotoxin type A has been used for the treatment of hyperhidrosis.ObjectiveTo perform a systematic review of the literature to identify evidence on the treatment approaches and outcomes associated with abobotulinumtoxinA (aboBoNT-A) treatment of hyperhidrosis.MethodsEMBASE, MEDLINE, and the Cochrane Library were searched for relevant observational studies, randomized controlled trials, and nonrandomized controlled trials. There were no date or country restrictions. Bibliographies of review articles and recent congress proceedings (2017-2019) were also searched. Articles were screened using predefined eligibility criteria and relevant data were extracted.ResultsOf 191 unique articles identified, 23 were considered relevant (3 observational studies, 10 nonrandomized controlled trials, and 10 randomized controlled trials). These articles provided data on axillary (13), palmar (7), and forehead (1) hyperhidrosis, compensatory hyperhidrosis of the back (1), Frey syndrome (1), and diabetic gustatory sweating (1). All studies reported that aboBoNT-A reduced sweating and no serious adverse events were observed. Patient satisfaction was high and improvements to quality of life were observed after aboBoNT-A treatment.LimitationsVariability in the injection technique when data were compared across studies.ConclusionThis study describes a range of treatment approaches and demonstrates positive outcomes of aboBoNT-A treatment for multiple types of hyperhidrosis. Botulinum neurotoxin type A has been used for the treatment of hyperhidrosis. To perform a systematic review of the literature to identify evidence on the treatment approaches and outcomes associated with abobotulinumtoxinA (aboBoNT-A) treatment of hyperhidrosis. EMBASE, MEDLINE, and the Cochrane Library were searched for relevant observational studies, randomized controlled trials, and nonrandomized controlled trials. There were no date or country restrictions. Bibliographies of review articles and recent congress proceedings (2017-2019) were also searched. Articles were screened using predefined eligibility criteria and relevant data were extracted. Of 191 unique articles identified, 23 were considered relevant (3 observational studies, 10 nonrandomized controlled trials, and 10 randomized controlled trials). These articles provided data on axillary (13), palmar (7), and forehead (1) hyperhidrosis, compensatory hyperhidrosis of the back (1), Frey syndrome (1), and diabetic gustatory sweating (1). All studies reported that aboBoNT-A reduced sweating and no serious adverse events were observed. Patient satisfaction was high and improvements to quality of life were observed after aboBoNT-A treatment. Variability in the injection technique when data were compared across studies. This study describes a range of treatment approaches and demonstrates positive outcomes of aboBoNT-A treatment for multiple types of hyperhidrosis." @default.
• W3048009634 created "2020-08-13" @default.
• W3048009634 creator A5006557972 @default.
• W3048009634 creator A5006663264 @default.
• W3048009634 creator A5007181593 @default.
• W3048009634 creator A5026106627 @default.
• W3048009634 creator A5065115759 @default.
• W3048009634 date "2021-11-01" @default.
• W3048009634 modified "2023-10-16" @default.
• W3048009634 title "Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review" @default.
• W3048009634 cites W1964837848 @default.
• W3048009634 cites W1974983692 @default.
• W3048009634 cites W1981800850 @default.
• W3048009634 cites W1982656188 @default.
• W3048009634 cites W2002048052 @default.
• W3048009634 cites W2022396903 @default.
• W3048009634 cites W2028147765 @default.
• W3048009634 cites W2038915663 @default.
• W3048009634 cites W2048741547 @default.
• W3048009634 cites W2051842182 @default.
• W3048009634 cites W2057908079 @default.
• W3048009634 cites W2058385573 @default.
• W3048009634 cites W2069563163 @default.
• W3048009634 cites W2069569849 @default.
• W3048009634 cites W2090975300 @default.
• W3048009634 cites W2096038178 @default.
• W3048009634 cites W2113573427 @default.
• W3048009634 cites W2121616296 @default.
• W3048009634 cites W2130633223 @default.
• W3048009634 cites W2134018648 @default.
• W3048009634 cites W2140225926 @default.
• W3048009634 cites W2142918848 @default.
• W3048009634 cites W2148806371 @default.
• W3048009634 cites W2165152060 @default.
• W3048009634 cites W2166766869 @default.
• W3048009634 cites W2168916287 @default.
• W3048009634 cites W2315468531 @default.
• W3048009634 cites W2315614768 @default.
• W3048009634 cites W2338273453 @default.
• W3048009634 cites W2622220612 @default.
• W3048009634 cites W2741921564 @default.
• W3048009634 cites W4242782090 @default.
• W3048009634 cites W4248059326 @default.
• W3048009634 cites W4255958927 @default.
• W3048009634 doi "https://doi.org/10.1016/j.jaad.2020.07.123" @default.
• W3048009634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32781184" @default.
• W3048009634 hasPublicationYear "2021" @default.
• W3048009634 type Work @default.
• W3048009634 sameAs 3048009634 @default.
• W3048009634 citedByCount "7" @default.
• W3048009634 countsByYear W30480096342021 @default.
• W3048009634 countsByYear W30480096342022 @default.
• W3048009634 countsByYear W30480096342023 @default.
• W3048009634 crossrefType "journal-article" @default.
• W3048009634 hasAuthorship W3048009634A5006557972 @default.
• W3048009634 hasAuthorship W3048009634A5006663264 @default.
• W3048009634 hasAuthorship W3048009634A5007181593 @default.
• W3048009634 hasAuthorship W3048009634A5026106627 @default.
• W3048009634 hasAuthorship W3048009634A5065115759 @default.
• W3048009634 hasBestOaLocation W30480096341 @default.
• W3048009634 hasConcept C126322002 @default.
• W3048009634 hasConcept C141071460 @default.
• W3048009634 hasConcept C168563851 @default.
• W3048009634 hasConcept C17744445 @default.
• W3048009634 hasConcept C189708586 @default.
• W3048009634 hasConcept C197934379 @default.
• W3048009634 hasConcept C199539241 @default.
• W3048009634 hasConcept C23131810 @default.
• W3048009634 hasConcept C2776478404 @default.
• W3048009634 hasConcept C2778650131 @default.
• W3048009634 hasConcept C2779473830 @default.
• W3048009634 hasConcept C71924100 @default.
• W3048009634 hasConcept C95190672 @default.
• W3048009634 hasConceptScore W3048009634C126322002 @default.
• W3048009634 hasConceptScore W3048009634C141071460 @default.
• W3048009634 hasConceptScore W3048009634C168563851 @default.
• W3048009634 hasConceptScore W3048009634C17744445 @default.
• W3048009634 hasConceptScore W3048009634C189708586 @default.
• W3048009634 hasConceptScore W3048009634C197934379 @default.
• W3048009634 hasConceptScore W3048009634C199539241 @default.
• W3048009634 hasConceptScore W3048009634C23131810 @default.
• W3048009634 hasConceptScore W3048009634C2776478404 @default.
• W3048009634 hasConceptScore W3048009634C2778650131 @default.
• W3048009634 hasConceptScore W3048009634C2779473830 @default.
• W3048009634 hasConceptScore W3048009634C71924100 @default.
• W3048009634 hasConceptScore W3048009634C95190672 @default.
• W3048009634 hasFunder F4320328455 @default.
• W3048009634 hasIssue "5" @default.
• W3048009634 hasLocation W30480096341 @default.
• W3048009634 hasLocation W30480096342 @default.
• W3048009634 hasOpenAccess W3048009634 @default.
• W3048009634 hasPrimaryLocation W30480096341 @default.
• W3048009634 hasRelatedWork W125306840 @default.
• W3048009634 hasRelatedWork W1965897301 @default.
• W3048009634 hasRelatedWork W1987742652 @default.
• W3048009634 hasRelatedWork W2189666756 @default.
• W3048009634 hasRelatedWork W2747457586 @default.
• W3048009634 hasRelatedWork W2992845476 @default.

• next